Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Coronary Microvascular Dysfunction in Atherosclerosis: Pathogenesis, Non-Invasive Screening, and Therapeutic Approaches

Teo James

Chronic low-grade inflammation is a critical factor in the development of coronary atherosclerosis, leading to various clinical manifestations ranging from mild asymptomatic conditions to severe outcomes such as stable angina. The dysfunction of coronary microvasculature, which consists of vessels with a diameter less than 500 μm, can result in structural and functional abnormalities, leading to inadequate dilation. This comprehensive investigation focuses on understanding the pathogenesis of coronary microvascular dysfunction and explores the potential of non-invasive screening techniques for early detection. Additionally, we assess the role of anti-inflammatory agents, including statins and immunomodulators like anakinra, tocilizumab, and tumor necrosis factor-alpha inhibitors, as potential therapeutic approaches to reduce cardiovascular events in atherosclerotic heart diseases.